Sells analytical laboratory instruments, chromatography columns and diagnostic testing systems to pharmaceutical and life-sciences companies, industrial and testing laboratories, and clinical, academic and government customers.
10-K for FY2025, filed Feb 23, 2026Waters Corporation (the “Company,” “we,” “our,” or “us”), a global leader in analytical instruments and software, has pioneered innovations…View ↗
The Company’s products are used by pharmaceutical, clinical, biochemical, industrial, nutritional safety, environmental, academic and…View ↗
On February 9, 2026, the Company completed the acquisition (the “BDS Business Acquisition”) of the Biosciences and Diagnostic Solutions…View ↗
The Company typically has a broad and diversified customer base that includes pharmaceutical accounts, other industrial accounts…View ↗
Customers generally pay for products within 30 to 60 days of shipment. Annual instrument-service and software-maintenance contracts are billed at the start of the term; service calls are charged when performed.
10-K for FY2025, filed Feb 23, 2026The Company recognizes revenue on product sales at the time control of the product transfers to the customer. Certain of the Company’s…View ↗
Payment terms and conditions vary among the Company’s revenue streams, although terms generally include a requirement of payment within 30…View ↗
Service revenue includes (1) service and software maintenance contracts and (2) service calls (time and materials). Instrument service…View ↗
10-K for FY2025, filed Feb 23, 2026
FY2025 revenue by product or service ↗$3.2B
10-K for FY2025, filed Feb 23, 2026
$3.2B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2025, filed Feb 23, 2026 |
62%
FY2022: 67%
|
Product, FY2025
$2B Sources
|
Sold outright |
|
Service
|
38%
FY2022: 33%
|
Service, FY2025
$1.2B Sources
|
Pharmaceutical and other industrial accounts, universities and government agencies buy the company’s laboratory products through direct sales and service teams; customers can also order consumables electronically or through a catalog.
10-K for FY2025, filed Feb 23, 2026
Yes. It kept 20 cents of every revenue dollar as net income in FY2025 and turned 17 cents into free cash flow.
8-K, filed Aug 4, 2026
The Company is raising all components of its full-year 2026 guidance, given better-than-expected results and broad strengthening in…View ↗
Growing. Revenue grew 14% in 4 years, from $2.8B in FY2021 to $3.2B in FY2025, about 3% a year.
Added diagnostics and biosciences
The portfolio has expanded beyond analytical instruments and laboratory consumables to include specimen collection and transport, infectious-disease and cancer testing systems, flow cytometry and multiomics tools.
10-K for FY2022, filed Feb 27, 2023 10-K for FY2025, filed Feb 23, 2026Waters Corporation (the “Company,” “WatersTM,” “we,” “our,” or “us”) is a specialty measurement company that operates with a fundamental…View ↗
On February 9, 2026, the Company completed the acquisition (the “BDS Business Acquisition”) of the Biosciences and Diagnostic Solutions…View ↗
Added light-scattering tools
The instrument range has grown beyond chromatography, mass spectrometry and thermal analysis to include Wyatt light-scattering and field-flow fractionation instruments.
10-K for FY2022, filed Feb 27, 2023 10-K for FY2025, filed Feb 23, 2026Waters Corporation (the “Company,” “WatersTM,” “we,” “our,” or “us”) is a specialty measurement company that operates with a fundamental…View ↗
The Company has two operating segments: Waters™ and TA™. Waters products and services primarily consist of high-performance liquid…View ↗
Competes with Agilent Technologies, Shimadzu, Bruker, Danaher, Thermo Fisher Scientific, PerkinElmer, NETZSCH-Geraetebau, Malvern PANalytical, Spectris, Anton-Paar, Merck, General Electric, Revvity, Cytek Biosciences, and bioMérieux
10-K for FY2025, filed Feb 23, 2026In the markets served by Waters, the Company’s principal competitors include: Agilent Technologies, Inc., Shimadzu Corporation, Bruker…View ↗
Loading...